Burjeel maintains a young asset fleet with substantial growth ramp-up opportunities driven by increasing utilization rates. The Group focuses on utilizing the existing invested infrastructure for super-specialty services to meet a growing market need.
With a demonstrated track record of ramping up assets to maturity, the Group is well-positioned to leverage its key asset, Burjeel Medical City, for substantial volume growth. The Group aims to increase the bed occupancy rate from 61% to 80% by 2027.
The Group has been adapting to evolving patient needs and optimizing its estate by repurposing some of its infrastructure. With a strong history of successfully growing patient volumes across the most complex and premium services, Burjeel expects to build on past success in this area further.
The focus on key specialities and investment in subspecialty and complex treatment lead to a rise in patient yield. Thanks to Burjeel Medical City, as a super-specialty unit, the Group aims to increase its yields further through its tertiary and quaternary care and by extending its complex capabilities.
Ensuring optimized operations is a key factor behind Burjeel’s success, with various centralization and digitization initiatives driving efficiency. The Group’s digital transformation and its operational and infrastructural investment are expected to result in substantial savings in both time and costs, leading to improved margins.
The Group invests significantly in digital capabilities to drive best practices across its operations and support the continued delivery of high-quality services. These investments have enabled Burjeel to efficiently manage its workforce and asset turnaround, resulting in higher profitability.
Burjeel Holdings employs a multi-pronged expansion strategy that leverages its international reputation for world-class healthcare provision and includes both local and international growth.